Posts in category: Uncategorized

The provision of joint replacement surgery in England is subject to socio-economic inequalities, despite a years-long effort to reduce them. A study of hip and knee surgeries over a ten-year period, published April 27 in the open access journal PLOS Medicine, concludes that care providers must take further action to address variation in access to these frequently performed operations.

For the well over 700 million people around the globe living with type 1 diabetes, getting a host immune system to tolerate the presence of implanted insulin-secreting cells could be life-changing.

Researchers have developed a novel way to detect whether a person follows a Mediterranean diet using a blood test and, applying this method, have shown that a Mediterranean diet is associated with lower risk of type 2 diabetes. Jakub Sobiecki of the University of Cambridge, U.K., and colleagues present these findings April 27 in the open access journal PLOS Medicine.

For breast cancer patients undergoing breast reconstruction after mastectomy, avoiding postoperative oral antibiotics does not reduce the risk of infections, reports a study in the May issue of Plastic and Reconstructive Surgery.

A leading testing expert says DNA genotype testing is revealing how most of us have a little Neanderthal in our blood, and how our unique DNA sequence can reveal our origins and track our ancestors’ migration over 50,000 years.

Type 2 diabetes and prediabetes are major public health burdens among adults, and Hispanics and Latinos in the United States are at increased risk for type 2 diabetes. Researchers at Baylor College of Medicine studied how avocado intake impacts the chance of developing type 2 diabetes. Their findings were published in the Journal of Diabetes Mellitus.

A recent study revealed that a protein important for neuron communication is associated with patient resistance to Alzheimer’s disease and may delay cognitive decline.

The team developed a deep learning AI model that can identify which at-risk infants have ROP that may lead to blindness if left untreated, and they hope their technique could improve access to screening in the many areas with limited neonatal services and few trained ophthalmologists.

Clinicians in an intensive care unit need to make complex decisions quickly and precisely, monitoring critically ill or unstable patients around the clock.

Erythropoietin, or Epo for short, is familiar from doping cases. But the body itself also produces this vital hormone. Now, for the first time, an international research team including UZH scientists has been able to identify the main producer of Epo: a subgroup of kidney cells called Norn cells. The findings could lay the foundation for the development of new therapies.